Topic Review
Extracellular Vesicles in Facial Aesthetics
Facial aesthetics involve the application of non-invasive or minimally invasive techniques to improve facial appearance. Extracellular vesicles (EVs) are attracting much interest as nanocarriers in facial aesthetics due to their lipid bilayer membrane, nanosized dimensions, biological origin, intercellular communication ability, and capability to modulate the molecular activities of recipient cells that play important roles in skin rejuvenation. Therefore, EVs have been suggested to have therapeutic potential in improving skin conditions, and these highlighted the potential to develop EV-based cosmetic products.
  • 546
  • 24 Jun 2022
Topic Review
BP230 Autoantibodies in Bullous Pemphigoid
Bullous pemphigoid (BP) is a subepidermal autoimmune blistering disease predominantly affecting elderly patients and carries significant morbidity and mortality. Patients typically suffer from severe itch with eczematous lesions, urticarial plaques, and/or tense blisters. BP is characterized by the presence of circulating autoantibodies against two components of the hemidesmosome, BP180 and BP230.
  • 545
  • 18 Jul 2022
Topic Review
Immunotherapy for Cutaneous Malignant Melanoma
Malignant melanoma (mM) is the leading cause of death among cutaneous malignancies. While its incidence is increasing, the most recent cancer statistics show a small but clear decrease in mortality rate. This trend reflects the introduction of novel and more effective therapeutic regimens, including the two cornerstones of melanoma therapy: immunotherapies and targeted therapies. Unlike chemotherapies or radiation, in which the therapy directly induces cancer cell death, immunotherapies stimulate the patient’s immune system to control and eliminate the tumor. Advantages of immunotherapies over traditional cancer treatments include increased durability for long-term control or even cure and more precisely targeted anti-tumor activity that spares healthy tissues, many times with comparable or even reduced overall toxicity. The high immunogenicity and somatic mutation burden of melanoma likely contribute to the success of immunotherapy. Treatments combining immunotherapies with targeted therapies, which disable the carcinogenic products of mutated cancer cells, have further increased treatment efficacy and durability. Toxicity and resistance, however, remain critical challenges to the field. There are three types of immunotherapies currently approved by the US Food and Drug Administration (FDA) for the treatment of advanced melanoma: (1) T-cell stimulating cytokines (i.e. interferon (IFN)-α2b and interleukin-2 (IL-2)); (2) T-cell exhaustion-mitigating immune checkpoint inhibitors (ICI); and (3) a dendritic cell (DC)-activating oncolytic virus (T-VEC). Still others, such as adoptive cell transfer (ACT), hold strong promise for the future.
  • 543
  • 20 Apr 2022
Topic Review
Maskne
The term maskne comes from the contraction of mask-related acne. It means a form of mechanical acne resulting from the continuous adherence and friction between skin and facial mask. It typically appeares as mild papular eruption accompained by comedones and seborrhea on the O-area of the face, especially on chin and cheecks. The prolonged use of mask generates also a hot-humid microclimate on skin surface modifyng sebum production and consequently microbiota.
  • 542
  • 09 Feb 2022
Topic Review
Transmission of Onychomycosis and Dermatophytosis between Household Members
Onychomycosis is a common fungal infection of the nail, caused by dermatophytes, non-dermatophytes, and yeasts. Predisposing factors include older age, trauma, diabetes, immunosuppression, and previous history of nail psoriasis or tinea pedis. Shared household equipment, including footwear, bedding, and nail tools, may transmit dermatophytes. The persistence of dermatophytes on household cleaning supplies, linen, and pets may serve as lasting sources of infection. Further investigation of the specific mechanisms behind household spread is needed to break the cycle of transmission, reducing the physical and social impacts of onychomycosis.
  • 542
  • 14 Mar 2022
Topic Review
Mycetoma: Development of Diagnosis and Treatment
Mycetoma describes a heterogeneous group of cutaneous and subcutaneous infections caused by either fungi (eumycetomas) or bacteria (actinomycetomas). It is characterized by a triad of clinical symptoms: painless subcutaneous tumor-like swelling, multiple sinuses and fistulas, and discharged grains in pus. This predominantly affects the feet in more than 70% of patients. It is endemic in the “mycetoma belt” regions, including Africa, South America, and South Asia. Autochthonous mycetoma is rare in the United States of America (USA). A Latin American immigrant with eumycetoma in the State of Maryland, USA. With millions of immigrants from endemic regions, the true number of mycetomas in the USA is most likely higher than currently recognized. With the aim to raise the awareness of clinicians about mycetoma, especially dermatologists and podiatrists, the development of the epidemiology, etiology, clinical presentations, pathogenesis, diagnosis, differential diagnosis, and treatment of mycetoma will be updated.
  • 541
  • 08 Aug 2022
Topic Review
Lichen Planus Activity and Damage Index (LiPADI)
Lichen planus (LP) is a chronic autoimmune disease that affects skin, oral and genital mucosa, and other sites. 
  • 540
  • 21 Jan 2022
Topic Review
Surgical Treatment in Hidradenitis Suppurativa
Hidradenitis suppurativa (HS) is a chronic, progressive inflammatory disorder of follicular occlusion with pubertal onset that presents as painful inflammatory nodules, sinus tracts, and tunnelling in apocrine-gland-rich areas, such as the axilla, groin, lower back, and buttocks. There are various options available for surgical intervention, with no optimal treatment, requiring an individualized approach for each patient. The choice of surgical treatment depends upon various factors, such as the chronicity and extent of disease, affected site, presence of long-standing lesions, and patient comorbidities. Surgical treatment in HS ranges from procedural treatments (e.g., laser) and minor surgery (e.g., incision and drainage and deroofing) to major surgery (e.g., wide local excision).
  • 537
  • 13 May 2022
Topic Review
Atopic Dermatitis and Food Allergy
Atopic dermatitis (AD) is a chronic inflammatory skin disorder characterized by intense pruritus, eczematous lesions, and relapsing course. It presents with great clinical heterogeneity, while underlying pathogenetic mechanisms involve a complex interplay between a dysfunctional skin barrier, immune dysregulation, microbiome dysbiosis, genetic and environmental factors. All these interactions are shaping the landscape of AD endotypes and phenotypes. In the “era of allergy epidemic”, the role of food allergy (FA) in the prevention and management of AD is a recently explored area.
  • 534
  • 05 Aug 2022
Topic Review
Pressure Injuries
Pressure injuries have been identified as one of the main health hazards among bedridden elderly people. Bedridden elderly people often stay in the same position for a long time, because they cannot switch positions; thus, the blood flow in the part of the body that is being compressed between the bed and their own weight is continuously blocked. As a result, redness and ulcers occur due to lacking oxygen and nutrients in the skin tissues, and these sites are often infected with microorganisms and, thus, become suppurative wounds, a condition commonly determined as pressure injuries. If left untreated, the pressure injury will recur with microbial infections, often resulting in cellulitis, osteomyelitis, and sepsis. The skin microbiome, in which many types of bacteria coexist, is formed on the skin surface. However, it remains unclear what characteristic of the skin microbiome among the bedridden elderly constitutes the development and severity of pressure injuries and the development of post-pressure injury infections.
  • 530
  • 29 Aug 2021
  • Page
  • of
  • 34
ScholarVision Creations